Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
189 studies found for:    Open Studies | "Psoriasis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Psoriasis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
Condition: Psoriasis
Interventions: Drug: Riboflavin;   Other: Placebo
2 Not yet recruiting The Association Between Psoriasis and Intestinal Bacterial Population
Condition: Psoriasis
Intervention:
3 Recruiting Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis
Condition: Psoriasis
Intervention:
4 Recruiting BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test
Condition: Psoriasis
Interventions: Drug: BAY1003803;   Drug: Clobetasol propionate;   Drug: Betamethasone/calcipotriene
5 Recruiting To Evaluate the Safety, Tolerability and Efficacy of Calcipotriene Foam, 0.005%, Versus Vehicle Foam in Pediatric Subjects (Ages 2-11) With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: STF 115469 Foam;   Drug: Vehicle Foam
6 Recruiting Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis
Condition: Psoriasis
Intervention:
7 Recruiting LEO 32731 for the Treatment of Moderate to Severe Psoriasis Vulgaris
Condition: Psoriasis Vulgaris
Interventions: Drug: LEO 32731;   Drug: LEO 32731 Placebo
8 Recruiting To Evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Calcipotriene 0.005%, Applied Under Maximal Use Conditions in 12-16 Year Olds With Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: calcipotriene
9 Not yet recruiting Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: Metformin;   Drug: Placebo;   Drug: Topical Coal tar;   Drug: Topical calcipotriol
10 Recruiting Cutaneous Microcirculation and Nervous Sensitivity in Psoriasis
Condition: Psoriasis
Interventions: Other: Acetylcholine iontophoresis;   Other: Sodium Nitroprussiate iontophoresis;   Other: ppi water iontophoresis;   Other: Laser Doppler recording
11 Recruiting Excimer Laser, Serum Markers & Psoriasis
Condition: Psoriasis
Intervention: Device: Excimer laser treatment
12 Recruiting Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Drug: Secukinumab;   Drug: Ustekinumab
13 Recruiting Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate
Condition: Psoriasis Vulgaris
Intervention: Drug: Methotrexate
14 Recruiting Psychotherapy for Patients With Psoriasis: Effects in Quality of Life
Condition: Psoriasis
Intervention: Behavioral: Psychotherapy
15 Not yet recruiting Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
Condition: Scalp Psoriasis
Interventions: Drug: 0.25% Desoximetasone cream (Topoxy®);   Drug: 0.25% Desoximetasone cream (Topicorte®);   Drug: Placebo
16 Not yet recruiting International Clinical Trial to Evaluate Efficacy and Safety of Multiple Injections of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: BCD-085;   Other: Placebo
17 Recruiting Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Interventions: Biological: etanercept;   Biological: etanercept (half dose);   Drug: placebo
18 Recruiting An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than 6 to Less Than 12 Years of Age
Condition: Psoriasis
Interventions: Drug: Ustekinumab 0.75 mg/kg;   Drug: Ustekinumab 45 mg;   Drug: Ustekinumab 90 mg
19 Not yet recruiting Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
Condition: Chronic Plaque Psoriasis
Interventions: Drug: PF-06700841;   Other: Placebo
20 Not yet recruiting Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: 0.5% Icotinib hydrochloride cream;   Drug: 1.0% Icotinib hydrochloride cream;   Drug: 2.0% Icotinib hydrochloride cream;   Drug: 4.0% Icotinib hydrochloride cream;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.